Soleno Therapeutics (SLNO) Current Assets: 2013-2019
Historic Current Assets for Soleno Therapeutics (SLNO) over the last 5 years, with Sep 2019 value amounting to $11.6 million.
- Soleno Therapeutics' Current Assets rose 1.72% to $11.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $11.6 million, marking a year-over-year increase of 1.72%. This contributed to the annual value of $24.7 million for FY2018, which is 37.10% up from last year.
- According to the latest figures from Q3 2019, Soleno Therapeutics' Current Assets is $11.6 million, which was down 30.13% from $16.6 million recorded in Q2 2019.
- Soleno Therapeutics' 5-year Current Assets high stood at $24.7 million for Q4 2018, and its period low was $3.8 million during Q2 2016.
- In the last 3 years, Soleno Therapeutics' Current Assets had a median value of $13.3 million in 2018 and averaged $14.6 million.
- Per our database at Business Quant, Soleno Therapeutics' Current Assets skyrocketed by 1,700.00% in 2015 and then tumbled by 54.00% in 2016.
- Over the past 5 years, Soleno Therapeutics' Current Assets (Quarterly) stood at $6.4 million in 2015, then crashed by 40.64% to $3.8 million in 2016, then soared by 373.37% to $18.0 million in 2017, then surged by 37.10% to $24.7 million in 2018, then climbed by 1.72% to $11.6 million in 2019.
- Its Current Assets was $11.6 million in Q3 2019, compared to $16.6 million in Q2 2019 and $20.9 million in Q1 2019.